Attend insightful Cepheid’s symposium presentations and explore our cutting-edge diagnostic tools. Counting down the days until we meet in Vienna, Austria! #ESCMID #InfectiousDisease Discover the full program: https://ow.ly/A77S50VfV9G
关于我们
Cepheid is dedicated to improving healthcare by pioneering molecular diagnostics that combine speed, accuracy, and flexibility. The company's GeneXpert? systems and Xpert? tests automate highly complex and time-consuming manual procedures, providing A Better Way for institutions of any size to perform world-class PCR testing. Cepheid’s broad test portfolio spans respiratory infections, blood virology, women’s and sexual health, TB and emerging infectious diseases, healthcare-associated infectious diseases, oncology and human genetics. The company’s solutions deliver actionable results where they are needed most – from central laboratories and hospitals to near-patient settings. For more information, visit https://www.cepheid.com. Cepheid is proud to be a part of Danaher. Danaher’s science and technology leadership puts Cepheid’s solutions at the forefront of the industry, so they can reach more people. Being part of Danaher means we can offer unparalleled breadth and depth of expertise and solutions to our customers. Together with Danaher’s other businesses across Biotechnology, Diagnostics, and Life Sciences, we unlock the transformative potential of cutting-edge science and technology to improve billions of lives every day.
- 网站
-
https://www.cepheid.com
Cepheid的外部链接
- 所属行业
- 生物技术研究
- 规模
- 5,001-10,000 人
- 总部
- Sunnyvale,CA
- 类型
- 上市公司
- 创立
- 1996
- 领域
- Molecular Diagnostics、Genetic Testing、Molecular Biology、Infectious Diseases、Cancer和PCR
地点
Cepheid员工
动态
-
Tuberculosis remains a significant global health challenge, and many countries still face gaps in #TB management. Can molecular tests revolutionize #tuberculosis control? #EndTB #FightingTBisEverything Read Cepheid’s Expert Perspective on key tools to fight TB in low-resource settings: https://ow.ly/95h450Vbqpg
-
Accurate diagnosis of #GroupAStrep supports #AntimicrobialStewardship and may reduce the number of patients inappropriately prescribed antibiotics. Learn more: https://ow.ly/lrZ050VcXaO
-
-
?? Breaking research published in the New England Journal of Medicine shows that treating male partners resulted in a lower rate of recurrence of bacterial vaginosis (BV) in their female sexual partners. This landmark study calls into question long-held assumptions about BV, potentially reclassifying it as a sexually transmitted infection (STI). ♀?BV is the most common vaginal condition in women ages 15-44,* affecting 1 in 3 reproductive-aged women. It is associated with an increased risk for preterm births, low birth weight, pelvic inflammatory disease, and endometritis. Women with BV have an increased incidence of concurrent trichomoniasis and an increased risk for HIV and other STIs such as chlamydia and gonorrhea.??? ? ?? Of annual BV-related healthcare costs, estimated at 4.8 billion USD, over half are attributed to recurrent disease.^ ?? Let’s change this together. Because every woman with vaginal symptoms deserves to know her status with timely, accurate testing to aid in the diagnosis and inform appropriate treatment for women AND their partners. NEJM Group #WomensHealth #BacterialVaginosis #SexualHealth #Vaginitis ? * https://lnkd.in/d3gSC5eC ^https://lnkd.in/dzETN8iZ ? https://lnkd.in/d4um2Rvk Read more: https://lnkd.in/gc6AQhPQ
-
-
?? A survivor of both COVID-19 and multidrug-resistant tuberculosis shares her story and her dedication to improving access to #MolecularDiagnostics for patients and health workers across the globe. #MTB #EndTB #FightingTBisEverything ??? Listen to her story on Cepheid's Insight Hub: https://ow.ly/8QN650Vbqrc
-
Today we are excited to recognize International Women’s Day by striking the Accelerate Action pose. #IWD2025 #BestTeamWins #AccelerateAction
-
-
-
-
-
+3
-
-
Hospitals and health systems in the U.S. have turned to the Quadruple Aim framework. Becker’s Hospital Review investigates how decentralized PCR testing supports this framework. Access the whitepaper on Cepheid's Insight Hub now: https://lnkd.in/gQKe9Ack
-
Early February marked one of the busiest weeks for the NHS, with more patients in hospitals than at any other point so far this winter, amid norovirus cases in hospitals continuing to rise.* Timely and accurate norovirus diagnostics can help support in expediting infection prevention measures such as rapid contact tracing and limit onward transmission. Speak to our experts about how fast PCR testing in as little as ~60 minutes with Xpert? Norovirus can help support winter pressures.^ #Norovirus #PCR https://lnkd.in/ggS6swmp * NHS England. Busiest week for hospitals this winter as norovirus cases continue to rise. https://lnkd.in/gEa94rmJ winter-as-norovirus-cases-continue-to-rise/ ^ For positive Norovirus results with early assay termination. Otherwise, full runtime is 90 minutes
-
-
Did you know that 99% of cervical cancers are associated with HPV infection?* Learn more about how HPV testing may help in preventing cervical cancer. #InternationalHPVDay #MolecularDiagnostics https://ow.ly/Gpav50V9WnL *https://ow.ly/Yv2350V9WnI
-